Effects of antioxidants on nerve and vascular dysfunction in experimental diabetes

Diabetes Research and Clinical Practice

Volumn 45, Issue 2-3, 1999, Pages 137-146

  Cameron, Norman E ^a   Cotter, Mary A ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Lipoic acid; Antioxidant; Blood flow; Diabetes; Free radicals; Ischemia; Nerve conduction velocity; Neuropathy; Nitric oxide; Vascular endothelium; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALDOSE REDUCTASE INHIBITOR; ALPHA TOCOPHEROL; AMINOGUANIDINE; ANTIOXIDANT; ASCORBIC ACID; ASCORBYL GAMMA LINOLENIC ACID; BETA CAROTENE; BUTYLCRESOL; DEFEROXAMINE; FREE RADICAL; GAMMA LINOLENIC ACID; GLUTATHIONE; NITRIC OXIDE; PROBUCOL; PROSTANOID; THIOCTIC ACID; TRIENTINE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FLOW; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; FATTY ACID METABOLISM; ISCHEMIA; NERVE CONDUCTION; NONHUMAN; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIOXIDANTS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; FATTY ACIDS, ESSENTIAL; HUMANS; NEURAL CONDUCTION; RATS; REACTIVE OXYGEN SPECIES;

EID: 0032836681     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(99)00043-1     Document Type: Article

References (67)

1. Low P.A., Lagerlund T.D., McManis P.G. Nerve blood flow and oxygen delivery in normal, diabetic and ischemic neuropathy. Int. Rev. Neurobiol. 31:1989;355-438.
2. Tesfaye S., Malik R., Ward J.D. Vascular factors in diabetic neuropathy. Diabetologia. 37:1994;847-854.
3. Cameron N.E., Cotter M.A. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab. Rev. 10:1994;189-224.
4. Cameron N.E., Cotter M.A. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes. 46:1997;S31-S37. (Suppl. 2).
5. Cameron N.E., Cotter M.A., Low P.A. Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am. J. Physiol. 261:1991;E1-E8.
6. Wright R.A., Nukada H. Vascular and metabolic factors in the pathogenesis of experimental diabetic neuropathy in mature rats. Brain. 117:1994;1395-1407.
7. Stevens E.J., Carrington A.L., Tomlinson D.R. Nerve ischaemia in diabetic rats: time-course of development, effects of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia. 37:1994;43-48.
8. Cameron N.E., Cotter M.A., Jack A., Hohman T.C. Inhibition of protein kinase C corrects nerve conduction and blood flow deficits in diabetic rats. Diabetologia. 40:1997;A31. (Suppl. 1).
9. Baynes J.W. Role of oxidative stress in the development of complications in diabetes. Diabetes. 40:1991;405-412.
10. Wolff S.P. Diabetes mellitus and free radicals. Br. Med. Bull. 49:1993;642-652.
11. Wieruszwysocka B., Wysocki H., Byks H., Zozulinska D., Wykretowicz A., Kazierczak M. Metabolic control quality and free radical activity in diabetic patients. Diabetes Res. Clin. Pract. 27:1995;193-197.
12. Low P.A., Nickander K.K. Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes. 40:1991;873-877.
13. Nickander K., Schmelzer J.D., Rohwer D., Low P.A. Effects of α-tocopherol-deficiency on indices of oxidative stress in normal and diabetic peripheral nerve. J. Neurol. Sci. 126:1994;6-14.
14. Nagamatsu M., Nickander K.K., Schmelzer J.D. et al. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
15. Low P.A., Nickander K.K., Tritschler H.J. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes. 46:1997;S38-S42. (Suppl. 2).
16. Sasaki H., Schmelzer J.D., Zollman P.J., Low P.A. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in long-standing diabetic rats. Acta Neuropathol. 93:1997;118-128.
17. Gryglewski R.J., Palmer R.M.J., Moncado S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 320:1986;454-456.
18. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B.A. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
19. Tesfamariam B., Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am. J. Physiol. 263:1992;H321-H326.
20. Taylor P.D., Poston L. The effect of hyperglycaemia on function of rat isolated mesenteric resistance artery. Br. J. Pharmacol. 113:1994;801-808.
21. Keegan A, Walbank H., Cotter M.A., Cameron N.E. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia. 38:1995;1475-1478.
22. Archibald V., Cotter M.A., Keegan A., Cameron N.E. Contraction and relaxation of aortas from diabetic rats: effects of chronic anti-oxidant and aminoguanidine treatments. Naunyn Schmiedeberg's Arch. Pharmacol. 353:1996;584-591.
23. Rosen P., Ballhausen T., Bloch W., Addicks K. Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: influence of tocopherol as antioxidant. Diabetologia. 38:1995;1157-1168.
24. Pieper G.M., Gross G.J. Oxygen free radicals abolish endothelium-dependent relaxation in diabetic rat aorta. Am. J. Physiol. 255:1988;H825-H833.
25. Mayhan W.G. Impairment of endothelium-dependent dilatation of the basilar artery during diabetes mellitus. Brain Res. 580:1992;297-302.
26. Kamata K., Miyata N., Kasuya Y. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97:1989;614-618.
27. McVeigh G.E., Brennan G.M., Johnston G.D. et al. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 35:1992;771-776.
28. Elliott T.G., Cockcroft J.R., Groop P.H., Viberti G.C., Ritter J.M. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin. Sci. 85:1993;687-693.
29. Johnstone M.T., Creager S.J., Scales K.M., Cusco J.A., Lee B.K., Creager M.A. Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation. 88:1993;2510-2516.
30. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., Attali J.R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 42:1993;1017-1025.
31. Morris S.J., Shore A.C., Tooke J.E. Responses of the skin microcirculation to acetylcholine and sodium nitroprusside in patients with NIDDM. Diabetologia. 38:1995;1337-1344.
32. Cotter M.A., Love A., Watt M.J., Cameron N.E., Dines K.C. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia. 38:1995;1285-1294.
33. Cameron N.E., Cotter M.A., Maxfield E.K. Antioxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia. 36:1993;299-304.
34. Cameron N.E., Cotter M.A., Archibald V., Dines K.C., Maxfield E.K. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia. 37:1994;449-459.
35. Karasu C., Dewhurst M., Stevens E.J., Tomlinson D.R. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats; comparison with essential fatty acids. Diabetologia. 38:1995;129-134.
36. Cameron N.E., Cotter M.A. Reversal of peripheral nerve conduction and perfusion deficits by the free radical scavenger, BM15.0639, in diabetic rats. Naunyn Schmiedeberg's Arch. Pharmacol. 321:1995;685-690.
37. Sagara M., Satoh J., Wada R. et al. Inhibition of development of peripheral neuropathy in streptozotocin-induced diabetic rats with N-acetylcysteine. Diabetologia. 39:1996;263-269.
38. Love A., Cotter M.A., Cameron N.E. Effects of the sulphydryl donor, N-acetyl-L-cysteine, on nerve conduction, perfusion, maturation, and regeneration following freeze-damage in diabetic rats. Eur. J. Clin. Invest. 26:1996;698-706.
39. Nickander K.K., McPhee B.R., Low P.A., Tritschler H. Alpha-lipoic acid: antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy. Free Rad. Biol. Med. 21:1996;631-639.
40. N.E. Cameron, M.A. Cotter, D.H. Horrobin, H.J. Tritschler, Effects of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids, Diabetologia 41 (1998) 390-399.
41. Cameron N.E., Cotter M.A. Neurovascular dysfunction in diabetic rats: potential contribution of autoxidation and free radicals examined using transition metal chelating agents. J. Clin. Invest. 96:1995;1159-1163.
42. G.M. Pieper, W. Siebeneich, Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine, J. Cardiovasc. Pharmacol. 31 (1997) 734-738.
43. Brownlee M. Glycation products and the pathogenesis of diabetic complications. Diabetes Care. 15:1992;1835-1843.
44. Lou M.F., Dickerson J.E., Garadi R., York B.M. Glutathione depletion in the lens of galactosemic and diabetic rats. Exp. Eye Res. 46:1988;517-530.
45. Hohman T.C., Banas D., Basso M., Cotter M.A., Cameron N.E. Increased oxidative stress in experimental diabetic neuropathy. Diabetologia. 40:1997;A549. (Suppl. 1).
46. 1 receptor antagonist. Am. J. Physiol. 269:1995;E530-E537.
47. A antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system. J. Pharmacol. Exp. Ther. 278:1996;1262-1268.
48. Kihara M., Low P.A. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol. 132:1995;180-185.
49. Maxfield E.K., Cameron N.E., Cotter M.A. Effects of diabetes on reactivity of sciatic vasa nervorum in rats. J. Diabet. Complications. 11:1997;47-55.
50. Love A., Cotter M.A., Cameron N.E. Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects. Eur. J. Pharmacol. 314:1996;33-39.
51. Love A., Cotter M.A., Cameron N.E. Effects of α-tocopherol on nerve conduction velocity and regeneration following a freeze lesion in immature diabetic rats. Naunyn Schmeideberg's Arch. Pharmacol. 355:1997;126-130.
52. Hunt J.V., Bottoms M.A., Mitchison M.J. Ascorbic acid oxidation: a potential cause of the elevated severity of atherosclerosis in diabetes mellitus. FEBS Lett. 311:1992;161-164.
53. Packer L.E., Slater T.F., Wilson R.L. Direct observation of a free radical interaction between vitamin E and vitamin C. Nature. 278:1979;737-738.
54. Keegan A., Cotter M.A., Cameron N.E. Autonomic neuropathy, corpus cavernosum innervation and endothelial responses: diabetic defects prevented by α-lipoic acid in rats. J. Peripheral Nerv. Syst. 2:1997;277.
55. Ziegler D., Hanefeld M., Ruhnau K.J. et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia. 38:1995;1425-1433.
56. Ziegler D., Schatz H., Gries F.A., Ulrich H., Reichel G. Effects of treatment with the antioxidant α-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Diabetes Care. 20:1997;369-373.
57. Keegan A., Cotter M.A., Archibald V., Cameron N.E. Metal chelator and free radical scavenger treatments prevent chronic aorta relaxation defects in diabetic rats. Diabetologia. 39:1996;A240. (Suppl. 1).
58. Lowitt S., Malone J.I., Salem A.F., Korthals J., Benford S. Acetyl-L-carnitine corrects altered peripheral nerve function in experimental diabetes. Metabolism. 44:1995;677-680.
59. Cameron N.E., Cotter M.A., Dines K.C., Maxfield E.K., Carey F., Mirrlees D.J. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myoinositol mechanism. Diabetologia. 37:1994;651-663.
60. Hotta N., Kaskuta H., Fukasawa H. et al. Effect of a potent new aldose reductase inhibitor (5-(3-thienyl)tetrazol-1-yl)acetic acid (TAT), on diabetic neuropathy in rats. Diabetes Res. Clin. Pract. 27:1995;107-117.
61. Hamada Y., Araki N., Horiuchi S., Hotta N. Role of polyol pathway in nonenzymatic glycation. Nephrol. Dialysis Transplant. 11:1996;95-98.
62. Fu M.X., Wells-Knecht K.J., Blackledge J.A. et al. Glycation, glycoxidation and cross-linking of collagen by glucose: kinetics, mechanisms, and inhibition of late stages of the Maillard reaction. Diabetes. 43:1994;676-683.
63. Cameron N.E., Cotter M.A. Rapid reversal by aminoguanidine of the neurovascular effects of diabetes in rats: modulation by nitric oxide synthase inhibition. Metabolism. 45:1996;1147-1152.
64. Cameron N.E., Cotter M.A., Hohman T.C. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia. 39:1996;172-182.
65. Cotter M.A., Cameron N.E. Effects of dietary supplementation with arachidonic acid rich oils on nerve conduction and blood flow in streptozotocin-diabetic rats. Prostaglandins Leukot. Essent. Fatty Acids. 56:1997;337-343.
66. Cameron N.E., Cotter M.A. Interaction between oxidative stress and γ-linolenic acid in the impaired neurovascular function of diabetic rats. Am. J. Physiol. 271:1996;E471-E476.
67. Cameron N.E., Cotter M.A. Comparison of the effects of ascorbyl γ-linolenic acid and γ-linolenic acid in the correction of neurovascular deficits in diabetic rats. Diabetologia. 39:1996;1047-1054.